Management of acute rhinosinusitis in primary care: Changing paradigms and the emerging role of intranasal corticosteroids

Primary Care Respiratory Journal

Volumn 17, Issue 3, 2008, Pages 148-155

  Ryan, Dermot ^a,b  

^a Woodbrook Medical Centre   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Acute rhinosinusitis; Antibiotics; Corticosteroids; Intranasal; Primary care

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BUDESONIDE; CEFACLOR; CEFUROXIME; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DOXYCYCLINE FOSFATEX; FLUNISOLIDE; MACROLIDE; MOMETASONE FUROATE; PLACEBO; PSEUDOEPHEDRINE; XYLOMETAZOLINE;

ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COUGHING; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRY NOSE; EPISTAXIS; FACE PAIN; GROWTH INHIBITION; HUMAN; MEDICAL PRACTICE; MONOTHERAPY; NOSE CONGESTION; PHARYNGITIS; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; RHINORRHEA; RHINOSINUSITIS; SIDE EFFECT; SINUS HEADACHE; VIRUS INFECTION;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; PRIMARY HEALTH CARE; RHINITIS; SINUSITIS;

EID: 51349146979     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2008.00050     Document Type: Review

References (57)

1. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117(3 Pt 2):S1-S7.
2. Fokkens W, Lund V, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps group. European Position Paper on Rhinosinusitis and Nasal Polyps 2008. Rhinology 2007;(Suppl 20):1-136.
3. Slavin RG. Nasal polyps and sinusitis. JAMA 1997;278(22): 1849-54.
4. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103(3 Pt 1):408-14.
5. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003;45(1):5-14.
6. Gwaltney JM, Phillips DC, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330(1):25-30.
7. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996;23(6): 1209-23.
8. Osguthorpe JD. Adult Rhinosinusitis: diagnosis and management. Am Fam Physician 2001;63(1):69-76.
9. Gonzales R, Steiner JF, Lum A, et al. Decreasing antibiotic use in ambulatory practice. Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999;281(16): 1512-19.
10. Dosh SA, Hickner JM, Mainous AG III, Ebell MH. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and sinusitis. J Fam Pract 2000;49(5):407-14.
11. Winstead W. Rhinosinusitis. Prim Care Clin Office Pract 2003;30(1):137-54.
12. Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev 2008;18(2):CD005149.
13. Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy 1989;44:116-22.
14. Desrosiers M, Klossek J-M, Benninger M. Management of acute bacterial rhinosinusitis: current issues and future perspectives. Int J Clin Pract 2006;60(2):190-200.
15. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988;105(3-4):343-9.
16. Lim M, Lew-Gor S, Darby Y, Brookes N, Scadding G, Lund VJ. The relationship between subjective assessment instruments in chronic rhinosinusitis. Rhinology 2008;45(2):144-7.
17. Melbye H, Stocks N. Point of care testing for C-reactive protein. A new path for Australian GPs? Aust Fam Physician 2006;35(7):513-16.
18. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice - a review. Brit J Gen Pract 2002;52(479):491-5.
19. Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995;311(6999): 233-6.
20. Small CB, Bachert C, Lund VJ et al. Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis. Am J Med 2007;120(4):289-94.
21. Poole MD. Acute bacterial rhinosinusitis: clinical impact of resistance and susceptibility. Am J Med 2004;117(Suppl 3A):29S-38S.
22. Leggett JE. Acute sinusitis: When - and when not - to prescribe antibiotics. Postgrad Med 2004;115(1):13-19.
23. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. Maxillary sinusitis in adults: an evaluation of placebo-controlled double-blind trials. Fam Pract 1997;14(2):124-9.
24. de Ferranti SD, Ioannidis JPA, Lau J, Anninger WV, Barza M. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A metaanalysis. BMJ 1998;317(7159):632-7.
25. Van Buchem FL, Knottnerus JA, Schrijnemaekers V-J, Peeters MF. Primarycare -based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997;349(9053):683-7.
26. Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scand J Prim Health Care 2000;18(1):44-7.
27. Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med 1996;2(3):183-8.
28. Diagnosis and Treatment of Acute Bacterial Rhinosinusitis. Summary, Evidence Report/Technology Assessment: Number 9, March 1999. Agency for Health Care Policy and Research, Rockville, MD. Available at: http://www.ahrq.gov/ clinic/epcsums/sinussum.htm. Accessed July 20, 2008.
29. Williams JW Jr, Aguilar C, Cornell J, et al. Antibiotics for acute maxillary sinusitis (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
30. De Sutter AI, De Meyere MJ, Christiaens TC, Van Driel ML, Peersman W, De Maeseneer JM. Does amoxicillin improve outcomes in patients with purulent rhinorrhea? J Fam Pract 2002;51(4):317-23.
31. Merenstein D, Whittaker C, Chadwell T, Wegner B, D'Amico F. Are antibiotics beneficial for patients with sinusitis complaints? A randomized, double-blind clinical trial. J Fam Pract 2005;54(2):144-51.
32. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002;50(Suppl S1):25-37.
33. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357(9271):1851-3.
34. Anon JB, Jacobs MR, Poole MD, et al. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(Suppl 1):1-45.
35. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN. The Alexander Project 1998-2000: susceptibility of pathogens isolated from communityacquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;5(2):229-46.
36. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21(6):1378-85.
37. Nissinen A, Grönroos P, Huovinen P, et al. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis 1995;21(5):1193-6.
38. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337(7):441-6.
39. Goossens H, Ferech M, Vander Stichele R, Elseviers M, for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459) :579-87.
40. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003;138(7):525-53.
41. Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/ dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006;11(3):e561-9.
42. Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician 2006;74(9):1510-16.
43. Kunisaki KM, Rice KL, Niewoehner DE. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: an appraisal of published evidence. Drugs Aging 2007;24(4):303-24.
44. Wood-Baker R, Walters J, Walters EH. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews. Respir Med 2007;101(3):371-7.
45. Barlan IB, Erkan E, Bakir M, Berrrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997;78(6):598-601.
46. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92(6):812-23.
47. Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002;89(3):271-8.
48. Dolor RJ, Witsell DL, Hellkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized, controlled trial. JAMA 2001;286(24): 3097-105.
49. Meltzer EO, Charous L, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. J Allergy Clin Immunol 2000;106(4):630-7.
50. Yilmaz G, Varan B, Yilmaz T, Gürakan B. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Eur Arch Otorhinolaryngol 2000;257(5):256-9.
51. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95.
52. Corren J. Intranasal corticosteroids for allergic rhinitis: How do different agents compare? J Allergy Clin Immunol 1999;104(4Pt1): S144-9.
53. AstraZeneca UK Limited. Rhinocort Aqua Nasal Spray (budesonide): summary of product characteristics [SPC]. Available at URL: http://medicines.org.uk/. Accessed August 23, 2008.
54. Nasarel Nasal Spray [prescribing information]. Miami, FL: Ivax Laboratories, Inc; 2006.
55. Allen and Hanburys. Beconase Aqueous Nasal Spray (beclometasone dipropionate): summary of product characterisitics [SPC]. Available at URL: http://medicines.org.uk/. Accessed August 23, 2007.
56. Schering-Plough Limited. Nasonex (mometasone furoate): summary of product characteristics [SPC]. Available at URL: http://medicines.org.uk/. Accessed August 23, 2007.
57. Sanofi-aventis.Nasacort (triamcinolone acetonide): summary of product characteristics [SPC]. Available at URL: http://medicines.org.uk/. Accessed August 23, 2007.